Two Sigma Investments’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,078
Closed -$1.83K 3440
2023
Q1
$1.83K Sell
14,078
-8
-0.1% -$2 ﹤0.01% 2919
2022
Q4
$2.31K Sell
14,086
-44,920
-76% -$18.8K ﹤0.01% 2765
2022
Q3
$38K Sell
59,006
-116,110
-66% -$171K ﹤0.01% 2338
2022
Q2
$426K Sell
175,116
-163,716
-48% -$455K ﹤0.01% 1883
2022
Q1
$1.37M Sell
338,832
-86,309
-20% -$473K ﹤0.01% 1537
2021
Q4
$3.4M Buy
425,141
+99,565
+31% +$1.17M 0.01% 1472
2021
Q3
$6.28M Buy
325,576
+168,176
+107% +$2.94M 0.01% 1060
2021
Q2
$2.17M Buy
157,400
+53,761
+52% +$637K ﹤0.01% 1789
2021
Q1
$936K Buy
+103,639
New +$758K ﹤0.01% 2385

Other funds holding PLXP

Two Sigma Investments's PLXP Position: Q2 2023 in Review

Two Sigma Investments sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 14,078 shares — an estimated $1.83K sold.

Two Sigma Investments first reported a position in PLXP in Q1 2021 and held it in 9 quarters. The position peaked at $6.28M in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

  • Two Sigma Investments reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Investments sold 14,078 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $1.83K.
  • Two Sigma Investments first reported a position in PLx Pharma Inc. Common Stock in Q1 2021 and held it in 9 quarters.
  • Two Sigma Investments's PLx Pharma Inc. Common Stock position peaked at $6.28M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.